Cargando…

Empagliflozin protects against atherosclerosis progression by modulating lipid profiles and sympathetic activity

BACKGROUND: Several large clinical trials have confirmed the cardioprotective role of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in patients with type 2 diabetes. However, whether empagliflozin, as an SGLT2i, could alleviate atherosclerosis progression in non-diabetic states remain unknown....

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yihai, Xu, Jiamin, Wu, Mingyue, Xu, Biao, Kang, Lina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802233/ https://www.ncbi.nlm.nih.gov/pubmed/33436015 http://dx.doi.org/10.1186/s12944-021-01430-y

Ejemplares similares

Empagliflozin Alleviates Atherosclerosis Progression by Inhibiting Inflammation and Sympathetic Activity in a Normoglycemic Mouse Model
por: Liu, Yihai, et al.
Publicado: (2021)

Cardioprotective Roles of β-Hydroxybutyrate Against Doxorubicin Induced Cardiotoxicity
por: Liu, Yihai, et al.
Publicado: (2021)

M2-like macrophages transplantation protects against the doxorubicin-induced heart failure via mitochondrial transfer
por: Liu, Yihai, et al.
Publicado: (2022)

Trophoblast Stem-Cell-Derived Exosomes Improve Doxorubicin-Induced Dilated Cardiomyopathy by Modulating the let-7i/YAP Pathway
por: Ni, Jie, et al.
Publicado: (2020)

Sympathetic Nervous System and Atherosclerosis
por: Wang, Yutang, et al.
Publicado: (2023)

Dapagliflozin protects against dilated cardiomyopathy progression by targeting NLRP3 inflammasome activation
por: Hu, Jiaxin, et al.
Publicado: (2023)

Empagliflozin Protects against Haloperidol Experimentally-Induced Ovarian Toxicity
por: Abdelzaher, Walaa Yehia, et al.
Publicado: (2023)

Empagliflozin protects against renal ischemia/reperfusion injury in mice
por: Wang, Qifeng, et al.
Publicado: (2022)

Sleep modulates hematopoiesis and protects against atherosclerosis
por: McAlpine, Cameron S., et al.
Publicado: (2019)

Hepatocyte Sirtuin 6 Protects against Atherosclerosis and Steatohepatitis by Regulating Lipid Homeostasis
por: Zhu, Yingdong, et al.
Publicado: (2023)

Cardiac Sympathetic Afferent Denervation Protects Against Ventricular Arrhythmias by Modulating Cardiac Sympathetic Nerve Activity During Acute Myocardial Infarction
por: Zhou, Mingmin, et al.
Publicado: (2019)

Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death
por: Hu, Zhaoyang, et al.
Publicado: (2021)

Transcriptomic Analysis Reveals the Protective Effects of Empagliflozin on Lipid Metabolism in Nonalcoholic Fatty Liver Disease
por: Ma, Yuting, et al.
Publicado: (2021)

Danon disease: a case report and literature review
por: Xu, Jiamin, et al.
Publicado: (2021)

Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis
por: Radlinger, Bernhard, et al.
Publicado: (2022)

Empagliflozin Ameliorates Progression From Prediabetes to Diabetes and Improves Hepatic Lipid Metabolism: A Systematic Review
por: Hossain, Md Fahad, et al.
Publicado: (2022)

Circulating exosomal miR-144-3p inhibits the mobilization of endothelial progenitor cells post myocardial infarction via regulating the MMP9 pathway
por: Liu, Yihai, et al.
Publicado: (2020)

Trajectories of Lipid Profile and Risk of Carotid Atherosclerosis Progression: A Longitudinal Cohort Study
por: Yu, Haixu, et al.
Publicado: (2022)

Chronic sympathetic driven hypertension promotes atherosclerosis by enhancing hematopoiesis
por: Al-Sharea, Annas, et al.
Publicado: (2019)

Effect of Empagliflozin Versus Placebo on Cardiac Sympathetic Activity in Acute Myocardial Infarction Patients with Type 2 Diabetes Mellitus: Rationale
por: Kubota, Yoshiaki, et al.
Publicado: (2018)

CD55 Deficiency Protects against Atherosclerosis in ApoE-Deficient Mice via C3a Modulation of Lipid Metabolism
por: Lewis, Ruth D., et al.
Publicado: (2011)

Hyaluronic acid-coated polymeric micelles with hydrogen peroxide scavenging to encapsulate statins for alleviating atherosclerosis
por: Mu, Dan, et al.
Publicado: (2020)

ATF3 protects against atherosclerosis by suppressing 25-hydroxycholesterol–induced lipid body formation
por: Gold, Elizabeth S., et al.
Publicado: (2012)

New insights into the role of empagliflozin on diabetic renal tubular lipid accumulation
por: Sun, Hong, et al.
Publicado: (2022)

Effects of blood lipid stability on progression of carotid atherosclerosis
por: Ding, Yu, et al.
Publicado: (2017)

Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial
por: Shimizu, Wataru, et al.
Publicado: (2020)

TDP43 Exacerbates Atherosclerosis Progression by Promoting Inflammation and Lipid Uptake of Macrophages
por: Huangfu, Ning, et al.
Publicado: (2021)

Sympathetic modulation by antihypertensive drugs
por: Katsurada, Kenichi, et al.
Publicado: (2021)

Glucose lowering by SGLT2-inhibitor empagliflozin accelerates atherosclerosis regression in hyperglycemic STZ-diabetic mice
por: Pennig, Jan, et al.
Publicado: (2019)

SIRT6 protects against endothelial dysfunction and atherosclerosis in mice
por: Xu, Suowen, et al.
Publicado: (2016)

The role of empagliflozin in the management of type 2 diabetes by patient profile
por: Hedrington, Maka S, et al.
Publicado: (2015)

Chaperone-mediated autophagy protects against atherosclerosis
por: Madrigal-Matute, Julio, et al.
Publicado: (2022)

The dual role of empagliflozin: Cardio renal protection in T2DM patients
por: Shafiq, Aimen, et al.
Publicado: (2022)

Progress in Sympathetically Mediated Pathological Pain
por: Chen, Si-Si, et al.
Publicado: (2015)

Untargeted metabolomic profiling in a patient with glycogen storage disease Ib receiving empagliflozin treatment
por: Tallis, Eran, et al.
Publicado: (2022)

Modulation of the sympathetic nervous system by renal denervation prevents reduction of aortic distensibility in atherosclerosis prone ApoE-deficient rats
por: Hohl, Mathias, et al.
Publicado: (2016)

Protective Role for Properdin in Progression of Experimental Murine Atherosclerosis
por: Steiner, Tanja, et al.
Publicado: (2014)

Sympathetic and Parasympathetic Modulation of Pupillary Unrest
por: Schumann, Andy, et al.
Publicado: (2020)

Does sympathetic nervous system modulate tumor progression? A narrative review of the literature
por: Stavropoulos, Ioannis, et al.
Publicado: (2020)

Sympathetic axonal sprouting induces changes in macrophage populations and protects against pancreatic cancer
por: Guillot, Jérémy, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_87j67aueed8issafknpdu93e7k